Design of studies on mechanisms (clinical translational studies)
Sample collection, sample handling and processing for adequate biobanks (serum, plasmas, DNA, RNA, tissue)
Different types of centrifuges
Ultra freezers (in collaboaration with Department of Biobanking, UUS)
Laboratory Methods (locally)
ELISA's
HPLC
Spectrophotometry
Flowcytometri
Aggregometri
Platelet-functional analyzers (PFA100, VerfyNow)
RNA-ekstraksjon
RT-PCR
Collaboration with Core Facilities milieus for cell culture studies etc.
Recent publications
Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I(2022) Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial J Intern Med DOI 10.1111/joim.13442, PubMed 34982486
Omland T, Prebensen C, Jonassen C, Svensson M, Berdal JE, Seljeflot I, Myhre PL(2021) Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19 Open Heart, 8(2) DOI 10.1136/openhrt-2021-001884, PubMed 34933965
Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ(2021) High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI Open Heart, 8(2) DOI 10.1136/openhrt-2021-001869, PubMed 34933964